Human Cytomegalovirus Envelope Glycoprotein B Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 54053 | Published Date: Oct 2024 | No. of Page: 95 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B INDUSTRY
    2.1 Summary about Human Cytomegalovirus Envelope Glycoprotein B Industry
    2.2 Human Cytomegalovirus Envelope Glycoprotein B Market Trends
        2.2.1 Human Cytomegalovirus Envelope Glycoprotein B Production & Consumption Trends
        2.2.2 Human Cytomegalovirus Envelope Glycoprotein B Demand Structure Trends
    2.3 Human Cytomegalovirus Envelope Glycoprotein B Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 CSJ-148
        4.2.2 CyMVectin
        4.2.3 TRL-345
        4.2.4 PPCM
        4.2.5 Cytomegalovirus Vaccine
        4.2.6 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Infectious Disease
        4.3.2 Oncology
        4.3.3 Women's Health
        4.3.4 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 CSJ-148
        5.2.2 CyMVectin
        5.2.3 TRL-345
        5.2.4 PPCM
        5.2.5 Cytomegalovirus Vaccine
        5.2.6 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Infectious Disease
        5.3.2 Oncology
        5.3.3 Women's Health
        5.3.4 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 CSJ-148
        6.2.2 CyMVectin
        6.2.3 TRL-345
        6.2.4 PPCM
        6.2.5 Cytomegalovirus Vaccine
        6.2.6 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Infectious Disease
        6.3.2 Oncology
        6.3.3 Women's Health
        6.3.4 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 CSJ-148
        7.2.2 CyMVectin
        7.2.3 TRL-345
        7.2.4 PPCM
        7.2.5 Cytomegalovirus Vaccine
        7.2.6 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Infectious Disease
        7.3.2 Oncology
        7.3.3 Women's Health
        7.3.4 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 CSJ-148
        8.2.2 CyMVectin
        8.2.3 TRL-345
        8.2.4 PPCM
        8.2.5 Cytomegalovirus Vaccine
        8.2.6 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Infectious Disease
        8.3.2 Oncology
        8.3.3 Women's Health
        8.3.4 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 CSJ-148
        9.2.2 CyMVectin
        9.2.3 TRL-345
        9.2.4 PPCM
        9.2.5 Cytomegalovirus Vaccine
        9.2.6 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Infectious Disease
        9.3.2 Oncology
        9.3.3 Women's Health
        9.3.4 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Astellas Pharma Inc.
        10.1.2 Trellis Bioscience, Inc.
        10.1.3 Vakzine Projekt Management GmbH
        10.1.4 VBI Vaccine Inc
        10.1.5 Vical Incorporated
    10.2  Human Cytomegalovirus Envelope Glycoprotein B Sales Date of Major Players (2017-2020e)
        10.2.1 Astellas Pharma Inc.
        10.2.2 Trellis Bioscience, Inc.
        10.2.3 Vakzine Projekt Management GmbH
        10.2.4 VBI Vaccine Inc
        10.2.5 Vical Incorporated
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
Table Human Cytomegalovirus Envelope Glycoprotein B Product Type Overview
Table Human Cytomegalovirus Envelope Glycoprotein B Product Type Market Share List
Table Human Cytomegalovirus Envelope Glycoprotein B Product Type of Major Players
Table Brief Introduction of Astellas Pharma Inc.
Table Brief Introduction of Trellis Bioscience, Inc.
Table Brief Introduction of Vakzine Projekt Management GmbH
Table Brief Introduction of VBI Vaccine Inc
Table Brief Introduction of Vical Incorporated
Table Products & Services of Astellas Pharma Inc.
Table Products & Services of Trellis Bioscience, Inc.
Table Products & Services of Vakzine Projekt Management GmbH
Table Products & Services of VBI Vaccine Inc
Table Products & Services of Vical Incorporated
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast (Million USD) by Region 2021f-2026f
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CSJ-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CyMVectin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure TRL-345 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PPCM Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cytomegalovirus Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Women's Health Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CSJ-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CyMVectin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure TRL-345 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PPCM Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cytomegalovirus Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Women's Health Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CSJ-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CyMVectin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure TRL-345 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PPCM Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cytomegalovirus Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Women's Health Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CSJ-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CyMVectin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure TRL-345 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PPCM Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cytomegalovirus Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Women's Health Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CSJ-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CyMVectin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure TRL-345 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PPCM Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cytomegalovirus Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Women's Health Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CSJ-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CyMVectin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure TRL-345 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PPCM Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cytomegalovirus Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Infectious Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Women's Health Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue (Million USD) of Astellas Pharma Inc. 2017-2020e
Figure Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue (Million USD) of Trellis Bioscience, Inc. 2017-2020e
Figure Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue (Million USD) of Vakzine Projekt Management GmbH 2017-2020e
Figure Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue (Million USD) of VBI Vaccine Inc 2017-2020e
Figure Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue (Million USD) of Vical Incorporated 2017-2020e
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Human Cytomegalovirus Envelope Glycoprotein B Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Cytomegalovirus Envelope Glycoprotein B Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Cytomegalovirus Envelope Glycoprotein B Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports